These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Targeted toxin therapy for malignant astrocytoma. Hall WA Neurosurgery; 2000 Mar; 46(3):544-51; discussion 552. PubMed ID: 10719849 [TBL] [Abstract][Full Text] [Related]
5. Advances in immunotoxin biology and therapy: a summary of the Fourth International Symposium on Immunotoxins. Frankel AE; FitzGerald D; Siegall C; Press OW Cancer Res; 1996 Feb; 56(4):926-32. PubMed ID: 8631036 [No Abstract] [Full Text] [Related]
6. Immunotoxin treatment of brain tumors. Hall WA Methods Mol Biol; 2001; 166():139-54. PubMed ID: 11217364 [No Abstract] [Full Text] [Related]
7. Clinical trials with Pseudomonas exotoxin immunotoxins. Pai LH; Pastan I Curr Top Microbiol Immunol; 1998; 234():83-96. PubMed ID: 9670614 [No Abstract] [Full Text] [Related]
8. Coupled cellular trafficking and diffusional limitations in delivery of immunotoxins to multicell tumor spheroids. Wenning LA; Murphy RM Biotechnol Bioeng; 1999 Mar; 62(5):562-75. PubMed ID: 10099565 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of anticancer immunotoxins. Choudhary S; Mathew M; Verma RS Drug Discov Today; 2011 Jun; 16(11-12):495-503. PubMed ID: 21511052 [TBL] [Abstract][Full Text] [Related]
10. Immunotoxin therapy for CNS tumor. Rustamzadeh E; Low WC; Vallera DA; Hall WA J Neurooncol; 2003; 64(1-2):101-16. PubMed ID: 12952291 [TBL] [Abstract][Full Text] [Related]
11. Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means. Kroll RA; Neuwelt EA Neurosurgery; 1998 May; 42(5):1083-99; discussion 1099-100. PubMed ID: 9588554 [TBL] [Abstract][Full Text] [Related]
12. Convection-enhanced delivery of immunotoxins and radioisotopes for treatment of malignant gliomas. Vandergrift WA; Patel SJ; Nicholas JS; Varma AK Neurosurg Focus; 2006 Apr; 20(4):E13. PubMed ID: 16709018 [TBL] [Abstract][Full Text] [Related]
13. Overexpressed cell surface interleukin-4 receptor molecules can be successfully targeted for antitumor cytotoxin therapy. Kawakami K; Kawakami M; Puri RK Crit Rev Immunol; 2001; 21(1-3):299-310. PubMed ID: 11642612 [TBL] [Abstract][Full Text] [Related]
14. Immunotoxin therapy. Hall WA Neurosurg Clin N Am; 1996 Jul; 7(3):537-46. PubMed ID: 8823781 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of transferrin receptor-targeted immunotoxins in brain tumor cell lines and pediatric brain tumors. Martell LA; Agrawal A; Ross DA; Muraszko KM Cancer Res; 1993 Mar; 53(6):1348-53. PubMed ID: 8443815 [TBL] [Abstract][Full Text] [Related]
18. Potent and specific killing of human malignant brain tumor cells by an anti-transferrin receptor antibody-ricin immunotoxin. Zovickian J; Johnson VG; Youle RJ J Neurosurg; 1987 Jun; 66(6):850-61. PubMed ID: 3033171 [TBL] [Abstract][Full Text] [Related]